{"domain":"breezebio.com","status":"valid","tier":"listed","authority":50,"verified":false,"title":"BreezeBio","summary":"Precision genetic medicines powered by the NanoGalaxy® non-viral delivery platform, targeting autoimmune disease and oncology.","llms_txt":"https://breezebio.com/llms.txt","llms_full_txt":"https://breezebio.com/llms-full.txt","last_checked":"2026-10-21T17:06:09.073Z","agent_terms":null,"categories":[],"capabilities":[],"inferred_tags":[],"audience":null,"agent_uses":[],"language":null,"platform_generated":null,"agent_summary":null,"llms_txt_cached":"https://agentwebmap.com/v1/domain/breezebio.com/llms.txt","agentic":"documentation","section_keys":["core-pages","corporate","legal","news","organization","scientific-context"],"section_partial":false,"section_indexed_at":"2026-10-21T17:06:17.477Z"}